Schwarz R D, Uretsky N J, Bianchine J R
Psychopharmacology (Berl). 1982;78(4):317-21. doi: 10.1007/BF00433733.
The effect of prostaglandins (PG) on amphetamine(AMPH)-induced circling was examined in mice unilaterally lesioned with 6-hydroxy-dopamine. At doses of 0.03-1.0 nmol/g, intraventricularly injected PGD2, PGE2, and PGF2 alpha all inhibited AMP-induced circling, while thromboxane-B2 (TxB2) was inactive at 1.0 nmol/g. The inhibition of circling was not due to alterations in body temperature as measured by rectal temperature changes. When injected intrastriatally, the same major PG inhibited AMP-induced circling at the lower doses of 0.01-0.1 nmol/g, while the PGE2 metabolite 13, 14-dihydro-15-keto-PGE2 was inactive at 0.1 nmol/g. PG administered alone did not procude circling. For both routes of administration, the order of potency was PGE2 greater than PGD2 greater than PGF2 alpha. These results suggest that PG can alter motor function governed by central dopaminergic pathways.
在单侧用6-羟基多巴胺损伤的小鼠中,研究了前列腺素(PG)对苯丙胺(AMPH)诱导的转圈行为的影响。脑室内注射剂量为0.03 - 1.0 nmol/g的前列腺素D2(PGD2)、前列腺素E2(PGE2)和前列腺素F2α(PGF2α)均能抑制AMPH诱导的转圈行为,而血栓素B2(TxB2)在1.0 nmol/g时无活性。转圈行为的抑制并非由直肠温度变化所测量的体温改变引起。当纹状体内注射时,相同的主要PG在0.01 - 0.1 nmol/g的较低剂量下抑制AMPH诱导的转圈行为,而前列腺素E2的代谢产物13,14-二氢-15-酮-前列腺素E2在0.1 nmol/g时无活性。单独给予PG不会引起转圈行为。对于两种给药途径,效力顺序为前列腺素E2大于前列腺素D2大于前列腺素F2α。这些结果表明,PG可改变由中枢多巴胺能通路控制的运动功能。